Hospital for Special Surgery’s selective fellowship programs prepare the next generation of leaders in orthopedic and rheumatologic medicine to deliver the highest level of care in any environment. The Hand and Upper Extremity Fellowship is a one-year program designed to provide candidates with up-to-the-minute diagnostic, operative, research, and clinical experience in their field. Fellows of the program work with six HSS hand and upper extremity experts using the latest technology to direct, manage, and schedule all of the hand clinic patients at the Hospital.
For more information on the HSS Fellowship Program, including the application form, access the link above.
Spine surgery is better than other treatments for a common and often debilitating back problem. That was the conclusion reached by HSS surgeon Frank P. Cammisa, Jr., MD, in a first-of-its-kind study published in May in the New England Journal of Medicine.
As part of the study, the progression of patients who underwent surgery for back pain caused by degenerative spondylolisthesis and spinal stenosis was compared to that of patients receiving nonsurgical therapy, including medicines, injections, and physical therapy.
“As the patients were treated, we saw a significant benefit for surgery over nonsurgical care in terms of relief of pain, return to function – basically their quality of life,” said Dr. Cammisa, Chief of the Spine Service at Hospital for Special Surgery.
For more information, read “For Patients with a Common Back Ailment, Surgery is the Way to Go” in the HSS Newsroom.
Rheumatologist Michael D. Lockshin, MD, has spent over 25 years studying clinical aspects of rheumatic disease and pregnancy. Dr. Lockshin is the director of the Barbara Volcker Center for Women and Rheumatic Disease and co-director of the Mary Kirkland Center for Lupus Research, as well as a professor of medicine and obstetrics-gynecology at Weill Cornell Medical College.
He is currently working with Jane E. Salmon, MD, on PROMISSE – a multimillion dollar, multicenter study funded by the National Institutes of Health that seeks to define biomarkers that predict a compromised pregnancy outcome in patients with lupus. “The PROMISSE study is the type of research that will lead to a new textbook that will rewrite the rules about lupus pregnancy,” said Dr. Lockshin.
For more information on these Centers and the PROMISSE study, access the following links:
View the latest issues of
Discovery to Recovery
to learn more about the pacesetting advances in basic and clinical research at Hospital for Special Surgery.
View Other Discovery to Recovery Extras: